Additionally, ILC2 may be the main driver of eosinophilia and asthma symptoms in conditions where CD4+ T cell activity has been dampened by steroid therapy recapitulated as knocking out recombinase activating gene (Rag−/−) in mice models [47,57,58]. The gene discussed is CD4; the disease is Increased total eosinophil count.